A Study of MHB046C Injection in Patients With Advanced Solid Tumors

NCT06985355 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Cancer

Interventions

DRUG: MHB046C

Sponsor

Minghui Pharmaceutical (Hangzhou) Ltd